PLSH (Panacea Life Sciences Holdings) Interest Expense: $-0.95 Mil (TTM As of Sep. 2025)


What is Panacea Life Sciences Holdings Interest Expense?

Panacea Life Sciences Holdings PLSH Interest Expense is $-0.95 Mil as of Sep. 2025. The stock has 6 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Panacea Life Sciences Holdings's interest expense for the three months ended in Sep. 2025 was $ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.95 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Panacea Life Sciences Holdings's Operating Income for the three months ended in Sep. 2025 was $ -0.17 Mil. Panacea Life Sciences Holdings's Interest Expense for the three months ended in Sep. 2025 was $ -0.01 Mil. Panacea Life Sciences Holdings did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Panacea Life Sciences Holdings  (OTCPK:PLSH) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Panacea Life Sciences Holdings's Interest Expense for the three months ended in Sep. 2025 was $-0.01 Mil. Its Operating Income for the three months ended in Sep. 2025 was $-0.17 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2025 was $0.00 Mil.

Panacea Life Sciences Holdings's Interest Coverage for the quarter that ended in Sep. 2025 is calculated as

Panacea Life Sciences Holdings did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Panacea Life Sciences Holdings Interest Expense Historical Data

* Premium members only.

The historical data trend for Panacea Life Sciences Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings Interest Expense Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Interest Expense
-1.51 -1.11 -2.05 -1.56

Panacea Life Sciences Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.46 -0.48 -0.47 -0.46 -0.01

Panacea Life Sciences Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.95 Mil mean?
Panacea Life Sciences Holdings (PLSH) has a Interest Expense of $-0.95 Mil as of Sep. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Panacea Life Sciences Holdings and its competitors.
Is Panacea Life Sciences Holdings' Interest Expense too high?
Panacea Life Sciences Holdings' current Interest Expense is $-0.95 Mil.
How does Panacea Life Sciences Holdings' Interest Expense compare to NPHC and OWPC?
Panacea Life Sciences Holdings' Interest Expense of $-0.95 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Panacea Life Sciences Holdings and its competitors. Panacea Life Sciences Holdings's current Interest Expense is $-0.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Interest Expense of $-0.95 Mil. The current Interest Expense is $-0.95 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Interest Expense is $-0.95 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.